Clinical Trials Directory

Trials / Completed

CompletedNCT05424042

Health, Aging and Later-Life Outcomes

Health, Aging and Later-Life Outcomes Pilot Trial (HALLO-P): A 9-month Randomized Pilot Trial of 3 Nutritional Interventions in 120 Older Adults With an Indication for Weight Loss

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this pilot research is to test the feasibility of two interventions focused on either reducing total calorie intake or reducing the total time that calories are ingested each day in older adults. Participation in this research will involve visits to our clinic for testing and weekly intervention visits (in-person or remote depending on group assignment) for nine months with total participation lasting about a year.

Detailed description

This pilot study is part of a larger planning process to design a full-scale randomized trial to evaluate the long-term effects of caloric restriction (CR) and time restricted eating (TRE) on the health of older adults. The specific objective of the HALLO-P is to collect data to inform the design of the full-scale randomized trial to evaluate the long-term effects of caloric restriction and time restricted eating in older adults. The pilot is a 9-month clinical trial. The pilot data will be used to refine recruitment criteria, estimate recruitment yields, and refine intervention approaches.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIn-Person Caloric Restriction20% CR delivered in-person by dietitian/coach
BEHAVIORALRemote Caloric Restriction20% reduction in caloric intake, meeting schedule, and physical activity goal delivered remotely.
BEHAVIORALTime-restricted8-hour TRE with ad libitum caloric intake. This group will undergo a 9-month dietary intervention targeting consumption of all daily caloric intake within an 8-hour window of time, with no restrictions on caloric intake.

Timeline

Start date
2022-07-05
Primary completion
2024-07-22
Completion
2024-07-22
First posted
2022-06-21
Last updated
2025-10-27
Results posted
2025-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05424042. Inclusion in this directory is not an endorsement.